FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

21643711000001109: Magnesium oxide 160mg tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 12-Dec 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
71652001000001111 Magnesium oxide 160mg tablets 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
71652101000001112 Magnesium oxide 160mg tablets 30 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

2 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium oxide 160mg tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet Has VMP Magnesium oxide 160mg tablets true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet Has specific active ingredient Magnesium oxide true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet VMP non-availability indicator Not available false Inferred relationship Existential restriction modifier
Magnesium oxide 160mg tablets 30 tablet VMP non-availability indicator Re-introduced true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Oromag 160 tablets (Fontus Health Ltd) 30 tablet Is a True Magnesium oxide 160mg tablets 30 tablet Inferred relationship Existential restriction modifier
Magdose 160mg tablets (TriOn Pharma Ltd) 30 tablet Is a True Magnesium oxide 160mg tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start